<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>PharmasVit</title>
  <link>https://pharmasvit.com/</link>
  <description>Trusted insight on vitamins, generics, and wellness.</description>
  <language>en</language>
  <lastBuildDate>Thu, 05 Nov 2026 16:20:07 GMT</lastBuildDate>
  <atom:link href="https://pharmasvit.com/feed.xml" rel="self" type="application/rss+xml"/>
  <item>
    <title>The Generic Drug Question: How FDA Bioequivalence Really Works and When the Brand Name Still Counts</title>
    <link>https://pharmasvit.com/generic-vs-brand-drugs-fda-bioequivalence-explained/</link>
    <guid isPermaLink="true">https://pharmasvit.com/generic-vs-brand-drugs-fda-bioequivalence-explained/</guid>
    <description>Nearly nine in ten prescriptions filled in the United States are for generic medications, yet confusion about their safety and effectiveness persists. We break down how the FDA actually approves generics, where the real differences lie, and the specific situations when paying for the brand name is justified.</description>
    <author>PharmasVit</author>
    <category>Medication Safety</category>
    <pubDate>Thu, 05 Nov 2026 16:20:06 GMT</pubDate>
  </item>
</channel>
</rss>